Freise, G., Gabler, A., and Liebig, S. (1978). Thorax, 33,[228][229][230][231][232][233][234] (Table 1) . Thirty-eight patients (8%) had tumours which were not resectable. Sixty-three (13-4%) died within the first four weeks after operation. Follow-up was not possible after discharge from hospital in 10 cases. The remaining 398 patients were followed up at outpatient consultations or from information sent by practitioners or other hospitals. One hundred and twenty-five patients (28-9%) survived five years; this survival rate is similar to those in other published studies.
In spite of reservations regarding retrospective studies, conclusions can be drawn regarding diagnosis, therapy, and prognosis. Questions concerning histological type, size, and site of tumour, and tumour stage can be answered only after an adequate postoperative interval. Five years after operation the patient who has apparently been successfully treated may die from a second primary carcinoma.
Patients under review
During the period from 1953 to 1968 471 patients at Heckeshorn Hospital had a thoracotomy for bronchial carcinoma (Table 1) . Thirty-eight patients (8%) had tumours which were not resectable. Sixty-three (13-4%) died within the first four weeks after operation. Follow-up was not possible after discharge from hospital in 10 cases. The remaining 398 patients were followed up at outpatient consultations or from information sent by practitioners or other hospitals. One hundred and twenty-five patients (28-9%) survived five years; this survival rate is similar to those in other published studies.
Results
The incidence of bronchial carcinoma in women is less than in men. In our series, females represented 10% of all thoracotomies, which is an average rate (Buchberger and Jenny, 1967; Sriboonma, 1967; Kutschera, 1968) . The reason why women have a better prognosis (Berndt, 1965; Watson, 1965) is uncertain. Our five-year survival rate in women is 34% and in men 27%. The women and involvement of lymph nodes (Table 6 ) is made, it becomes clear that the T4 cases (tumour extending beyond the lung) have the worst prognosis. Nevertheless, 6% of T4 patients have a five-year survival. Therefore, it can be stated, contrary to the opinion of Dittrich (1971) , that there is a chance of cure in some T4 cases (Wassner and Hauser, 1967; Zeidler and Linder, 1973) . The influence of lymph node metastasis on survival is clearly shown by using the TNM formula. Although some authors (Rienhoff et al., 1965) have reported that lymph node metastases are not of major importance to survival, it must be noted that in several reports an exact distinction between lymph node stages (N1 and N2 or N3) is not made (Maassen, 1967) . Long-term results are better In spite of this we do not refuse resection to these patients (Gabler and Freise, 1971 One-fifth of Salzer's (1971) cases had peripheral carcinomas. He considers that improved radiographic diagnosis will reveal an increased number of peripheral carcinomas. Long-term survival rates in his material are similar in both groups. Dittrich (1971) considers that classification into central and peripheral carcinomas is not necessary because misinterpretations of antero-posterior radiographs may occur. He considers tumour staging by the TNM classification at thoracotomy to be decisive. In our opinion, this concept should be followed.
The site of origin of the carcinoma in our 433 resected cases is shown in the Figure. The best results (34 3% five-year survival) were obtained from resection when the carcinoma was situated in the right upper lobe. The five-year survival rate was 31 2% for tumours of the left lower lobe, 26 4% for the upper lobe, 26 8% for the right lower lobe, and 18 8% for tumours situated in the middle lobe. Figure Tumour site and five-year survival rate. Schoen and Stoehr (1971) have pointed out that the upper lobes are affected more often than the lower, and the right lung more often than the left. Similar observations have been made by Hoffmann et al. (1969) . Huwe (1959) has reported a 17 8% five-year survival for right upper lobe tumours.
Salzer (1971) has reported that the most favourable long-term survival rates are for carcinoma in the right upper lobe, as we have noted. Other authors (Sriboonma, 1967; Hoffmann et al., 1969; Schoen and Stoehr, 1971) have described favourable long-term survival rates for bronchial carcinoma in the left upper lobe. Carcinoma of the left lower lobe is considered to have an unfavourable prognosis (Sriboonma, 1967, 127%; Schoen and Stoehr, 1971 , 145% five-year survival rates). Schoen and Stoehr (1971) and Hoffmann et al. (1969) consider that the frequency of contralateral lymph-node involvement in the left lower lobe tumours is responsible for the worse result. Hoffmann et al. (1969) , moreover, point to frequent abdominal metastases in carcinoma of the left lower lobe and recommend preliminary exploration of the abdomen in left lower lobe carcinoma. Our data, however, do not support this view of the poor prognosis of left lower lobe carcinoma.
INFLUENCE OF SIZE OF TUMOUR
The frequency of metastases in cases of resected peripheral bronchial carcinoma is shown in Table  7 . Whereas there is no statistically significant difference in the frequency of metastases between the first and second groups, there is a significant difference between groups 2 and 3 and a highly significant difference between groups 1 and 3.
These results in our series relate to a tumour stage without proof of lymph node metastasis at the time of operation, that is, stage T1/T2 N, Mo. Our experience confirms the general opinion that, in patients with large tumours, the chances of cure are less than when the tumour is small. Resection of large peripheral tumours may be considered a palliative procedure to prevent complications caused by tumour necrosis, such as excessive sputum or severe bleeding. Jones et al. (1967) 11 in 89 cases. The absolute criterion for accepting late recurrence is the development of carcinoma in the bronchus or parenchyma adjacent to the site of resection. If the histological type of the primary tumour and the recurrence is the same, it seems unwarranted to consider them as two separate primary tumours. For more than five years after operation we observed 11 out of 125 patients in whom tumour tissue was found close to the site of the resected primary and of a similar histological type. Two of our patients had late recurrences at the site of resection only, four had developed metastases in regional lymph nodes, four showed generalised metastases, and one had a metastasis in the other lung. The time interval before late recurrence was on average six years, and the maximum 14 years after operation (Table 8 ). All histological types of bronchial carcinoma were found and there was no relation between tumour stage at the time of operation and late recurrence.
The late development of malignant tissue in regional lymph nodes indicates metastasis (Regele and Wagner, 1966) . There should be no doubt about associating the resected tumour with the nodes when they are situated in the drainage area of the resected carcinoma, when the same histo-G. Freise, A. Gabler, and S. Liebig logical type is observed, and no primary is found. We have not observed late metastasis limited to local lymph nodes only. In our four cases with late lymph node metastasis occurring between the sixth and the tenth year after operation, metastasis was also found in the lung. It was not certain where the first evidence of late metastasis had occurred. In spite of finding the same histological type of tumour in all four cases, it was difficult to decide whether a late metastasis or a new primary with regional lymph node metastasis was present. The opinon of the pathologist may help in deciding between late metastasis and a second primary. The same difficulty applies to four other cases in which tumours in other parts of the lung developed between the sixth and the tenth year after operation. If the histological type corresponded to that of the original tumour the new development was considered as a late metastasis. In our eight cases of late metastasis, all cell types of tumours were found. With regard to the tumour stage, even the most favourable one, T2 N0, was represented six times.
The diagnosis of a second primary in the lung is sometimes justified. The increasing number of successfully resected tumours will increase the number of patients developing a second primary (Chaudhuri, 1971) . Considering also the influence of inhaled carcinogenic substances on the bronchus (Hughes and Blades, 1961; Ott and Titscher, 1969) and presuming an organ disposition for developing (Warren and Gates, 1932; Steele, 1963) , the occurrence of a second bronchial carcinoma is not surprising. Women with carcinoma of the breast develop a second carcinoma after mastectomy in the other breast six times more frequently than do controls (Desaire, 1949) . On these criteria we have diagnosed two second carcinomas of the lung. In both patients eight and 11 years after resection of the primary a second bronchial carcinoma of another histological type developed in the lung, and with its own lymph node metastasis. The incidence of 2 in 125 cases is low. But the occurrence of a second carcinoma of the lung is no longer to be considered a rarity (Brock, 1964; Smith, 1966; Cacers and Felson, 1972) .
Altogether 20 of 125 patients (16%) surviving more than five years after operation died of a late manifestation of their bronchial carcinoma. Two developed a new primary in the lung. Moreover, two patients developed an extrapulmonary malignancy before the late manifestation of lung carcinoma appeared. In six other patients a second malignancy was diagnosed up to 12 years after lung resection (Table 8) .
Conclusions
Depending on the stage of the tumour, 6-46%-on average 28 9%-of all patients operated upon have survived five years and, of these, a high percentage are not cured. One cannot be satisfied with these results. With regard to the operative procedure, it has been proved that even unfavourable cases have a chance of long-term survival and, even if it is small, the chance should be taken (Smith, 1970; Ashor et al., 1975) . Large tumours, lesions involving the mediastinum or thoracic wall, or carcinomas with mediastinal lymph node metastasis can be operated upon successfully. In our opinion, the decision to operate on these patients is limited only by the risks of a thoracotomy in unresectable cases. In our patients, the rate of exploratory thoracotomy without resection is relatively low, namely, 8% with a mortality of 3%. From our experience, survival is decreased only slightly by exploratory thoracotomy. These facts indicate the value of resection even in patients with an unfavourable prognosis in order to give the only chance of cure.
